Aims: To summarise the metabolic reactions to niacin that may result in flushing also to critically evaluate flushing mitigation study. flushing. An antagonist towards the DP1 receptor (laropiprant) coupled with an ER niacin formulation can decrease flushing; nevertheless, significant residual flushing happens with clinically-relevant dosages. Conclusions: Niacin can be an appealing option for dealing with… Continue reading Aims: To summarise the metabolic reactions to niacin that may result